Skip to main content
. Author manuscript; available in PMC: 2022 Feb 9.
Published in final edited form as: Expert Rev Vaccines. 2017 Dec 29;17(2):145–161. doi: 10.1080/14760584.2018.1418665

Table 1.

Rotavirus vaccine response in infants with and without history of breastfeedinga.

Reference Location Income groupc Vaccine No of Doses Measured outcomes Type of feeding
p-Value
BF Non-BF
Protection against RVGE
Gastanaduy et al. 2016 [35] Botswana UM RV1 2 Effectivenessb after 1 or 2 years (95% CI) 50 (−12, 78) 51 (−18, 80) NS
Gruber et al. 2017 [49] Kenya and Mali L, LM RV5 3 Efficacy after 1 year (95% CI) 49 (28–63) 52 (−13, 80) NS
Efficacy after 2 years (95% CI) 29 (14–41) 37 (−4, 62) NS
Gruber et al. 2017 [49] Bangladesh and Vietnam LM RV5 3 Efficacy after 1 year (95% CI) 53 (25–71) 61 (−23, 88) NS
Efficacy after 2 years (95% CI) 38 (13–56) 60 (12, 82) NS
Rennels et al. 1995 [52] USA H RRV-S1 3 Efficacy after 2 years (95% CI) 28 (−43, 63) 39 (−19, 69) NS
RRV-TV 3 Efficacy after 2 years (95% CI) 51 (−6–77) 50 (0–75) NS
Goveia et al. 2008 [51] USA H WC3 Efficacy after 1 year (95% CI) 68 (54–78) 68 (46–82) NS
Vesikari et al. 2012 [50] Europe H RV1 2 Efficacy after 1 year (95% CI) 86 (77–92) 91 (73–98) NS
Efficacy after 2 years (95% CI) 69 (56–78) 89 (64–97) NS
Immunogenicity
Bautista-Marquez et al. 2016 [53] Mexico UM RV1 2 RV-IgA seroresponse GMT (95% CI) 236 (147–378) 578 (367–910) 0.007
Stool RV-vaccine shedding rate 22% 43% 0.016
Friedman et al. 1993 [54] Israel H RRV-TV 2 RV-IgA seroconversion rate 50% 60% NS
Rennels et al. 1995 [52] USA H RRV-S1 3 RV-IgA seroconversion rate 68% 71% NS
RRV-TV 3 RV-IgA seroconversion rate 71% 72% NS
Vesikari et al. 2012 [50] Europe H RV1 2 RV-IgA seroconversion rate 86% 89% NS
RV-IgA seroresponse GMT (95% CI) 185 (161–214) 232 (186–288) NS
a

Full-dose vaccination studies assessing the effect breast-feeding vs bottle feeding. History of infants’ feeding practices was collected by parents or guardians.

b

Against severe RVGE.

c

World Bank list of economies (December 2016) low-income (L) economies are defined as those with a GNI per capita, of $1,025 or less in 2015; lower middle-income (LM) economies are those with a GNI per capita between $1,026 and $4,035; upper middle-income (UM) economies are those with a GNI per capita between $4,036 and $12,475; high-income (H) economies are those with a GNI per capita of $12,476 or more.

RV: rotavirus; BF: rreastfeeding; RVGE: rotavirus gastroenteritis; NS: non-statistically significant (p > 0.05); OR: odds ratio, GMT: geometric mean titer; RRV-S1: rhesus-human reassortant monovalent serotype 1; RRV-TV: rhesus-human reassortant tetravalent; RV1: rotarix; RV5: rotateq.